-

LILM Stock News: Robbins LLP Investigates Lilium N.V. (LILM) f/k/a Qell Acquisition Corp. (QELL) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Lilium N.V. (NASDAQ: LILM, LILMW, QELL, QELLW) and its officers and directors to determine whether they breached their fiduciary duties and violated securities laws regarding the Company's ability to launch the Lilium Jet. Lilium purports to be a next-generation transportation company focused on developing an electric vertical take-off-and-landing ("eVTOL") aircraft for use in a new type of high-speed air transportation for people and goods.

If you would like more information about our investigation into Lilium N.V.'s misconduct, click here.

What is this Case About: According to a complaint filed against Lilium, the documents filed in support of the business combination between it and Qell Acquisition Corp. touted the Company's technology, team, and resources, and explained that the money raised from the business combination would "be used to fund the commercial launch of Lilium's 7-Seater Jet." However, defendants failed to disclose that Lilium had overstated the Lilium Jet's design and capabilities and its timely certification. Further, Lilium misrepresented its ability to obtain or create the necessary batteries for the Lilium Jet and failed to disclose the merger would not generate enough cash to commercially launch the Lilium Jet.

On March 14, 2022, market analyst Iceberg Research released a report entitled "LILIUM NV – THE LOSING HORSE IN THE EVTOL RACE," which detailed the current state of Lilium. Specifically, the report contends that Lilium is not on track to meet its certification timeline, the energy density of battery cells required by Lilium are currently not available commercially, and the Company only has 18 more months of cash on hand. On this news, Lilium's stock price fell 34% per share, to close at $2.44 per share on March 14, 2022.

Next Steps: If you acquired shares of Lilium N.V. (LILM) between March 30, 2021 and March 14, 2022, you have legal options. Contact us for more information.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Lilium N.V. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:LILM

Release Summary
LILM Stock News: Robbins LLP Investigates Lilium N.V. (LILM) f/k/a Qell Acquisition Corp. (QELL) on Behalf of Shareholders
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Bath & Body Works, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Bath & Body Works, Inc. (NYSE: BBWI) securities between June 4, 2024 and November 19, 2025. Bath & Body Works is a specialty retailer of home fragrance and body care products. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegati...

Investor Notice: Robbins LLP Informs Investors of the Ardent Health, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegati...

Investor Notice: Robbins LLP Informs Investors of the Varonis Systems, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Varonis Systems, Inc. (NASDAQ: VRNS) securities between February 5, 2025 and October 28, 2025. Varonis is a global security company that provides software products and services to discovery and classify critical data, remediate exposures, and detect advanced threats with the help of AI-powered technologies. For more information, submit a form,...
Back to Newsroom